#USA #New York #Pomerantz LLP #FTC Lawsuit #Hims & Hers

Pomerantz Law Firm Investigates Claims Against Hims & Hers Health, Inc.

Recently, Pomerantz LLP, a well-regarded plaintiffs’ firm known for handling class action lawsuits, has begun investigating claims made by investors against Hims & Hers Health, Inc. (NYSE: HIMS). The firm specializes in securities fraud litigation, and is currently focused on allegations regarding the company’s conduct that could potentially have impacted its stock and investors' interests significantly.

Allegations and Background

On July 29, 2026, the Federal Trade Commission (FTC) filed a lawsuit against Hims, accusing the healthcare technology company of engaging in deceptive privacy practices. According to the FTC, Hims unlawfully shared sensitive medical information about its customers with various third-party advertisers such as Meta Platforms and Snap. The ramifications of these allegations have been severe; upon the announcement of the FTC lawsuit, Hims’ share price plummeted by $4.32, representing a steep decline of approximately 14.73% to settle at $25.00.

Compounding these challenges, on August 21, 2026, Bloomberg reported that Hims had received notice from Visa regarding a sharp rise in customer complaints linked to their weight-loss subscription service. Internal documentation indicated that excessive disputes from customers led Visa to enroll Hims in its Acquirer Monitoring Program, which comes with additional costs for each dispute—a concerning prospect for the company’s financial standing. Following this revelation, shares fell again, losing $2.70 or nearly 8% of their value, closing at $31.08.

A Call to Action for Investors

Investors who may have been adversely affected by these circumstances are encouraged to reach out to Pomerantz LLP for further information and assistance in potentially joining a class action suit. Danielle Peyton, an attorney at Pomerantz, is the main point of contact for those interested and can be reached through email or telephone at the provided contact details.

With over 85 years of legal expertise, Pomerantz has established itself as a leader in protecting investors’ rights. Founded by Abraham L. Pomerantz, the firm has long been at the forefront of securities class actions, fighting to recuperate losses for those wronged by corporate malfeasance. By investigating the claims against Hims, Pomerantz upholds its commitment to transparency and ethical conduct in business practices.

Conclusion

The unfolding situation at Hims calls for significant attention from investors and stakeholders. As legal proceedings progress, updates and outcomes are likely to emerge, keeping investors informed and engaged throughout the process. Arbiter and protector of shareholder interests, Pomerantz Law Firm continues to play a critical role in navigating the complexities of securities litigation, ensuring accountability in corporate America. While this particular case evolves, investors should remain vigilant of further developments concerning Hims & Hers Health, Inc.

For those considering next steps, acting swiftly may be crucial to safeguard their investments and rights. Pomerantz LLP is prepared to assist with legal guidance and representation to bolster investors' claims in the face of these serious allegations.